← FDA Drug Approvals (Drugs@FDA)

EMEND

NDA · New Drug Application · Sponsor: MSD · Approved 2003-03-26

Drug application

FDA Application #

NDA021549

Application type

New Drug Application

Brand name

EMEND

Generic name

APREPITANT

Active ingredients

APREPITANT

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

MSD

Manufacturer

Merck Sharp & Dohme LLC

First approval

2003-03-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown